The Corona G42 vaccine has been claimed to have obtained an emergency use authorization by the Chinese authorities.
“This Covid-19 vaccine candidate has obtained an Emergency Use Permit from the People’s Republic of China (PRC) Drug Supervisory Regulator, namely the National Medicines Products Administration (NMPA) in July 2020 based on the results of phase 1 dan 2 clinical trials and has obtained halal certification,” said the Head of BPOM Penny Kusumastuti Lukito in a written statement, Selasa (September 1).
Sinopharm has previously conducted phase one and two clinical trials, then a phase three clinical trial will be conducted in the UAE with a total of 22,000 participants from 119 world-renowned nationalities so that the clinical trials can provide valid results.
Head of the Food and Drug Supervisory Agency (BPOM) Penny Kusumastuti Lukito delivers a press statement at the BPOM hall building, Jakarta, Senin, Agustus 8, 2016.
Penny said the Indonesian government had secured the UAE’s commitment to providing 10 million Covid-19 vaccines for Indonesia. Kimia Farma is also working on this vaccine.
Sinopharm-G42 and Kimia Farma vaccines are vaccine candidates that will be used in Indonesia.
Apart from Sinopharm, there are two other vaccine candidates that will be used, namely the Sinovac vaccine in collaboration with Bio Farma Company, and Genexine in collaboration with Kalbe Farma Company.
The three of them are vaccine candidates from the Indonesian government’s international cooperation.
While at home, the Ministry of Research and Technology or the National Research and Innovation Agency (BRIN) is collaborating with the Eijkman BioMolecular Institute (LBM) in developing the red and white vaccine.
Sementara itu, the Spokesperson for the Covid-19 Handling Task Force Wiku Adisasmito said that the procurement of the corona vaccine (Covid-19) does not guarantee people’s lives will return to normal.
Based on studies and current conditions, said Wiku, patients recovering from corona also have the chance to contract again.
Wiku appealed to the public to keep trying to prevent by always adhering to health protocols for an undetermined period of time.